Status:
RECRUITING
Early Integration of Palliative and Supportive Care in Cellular Therapy
Lead Sponsor:
Alberta Health Services, Calgary
Collaborating Sponsors:
Alberta Cancer Foundation
University of Victoria
Conditions:
Leukemia
Lymphoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Research has shown that early palliative care in cancer care is associated with improved symptom management, better prognostic understanding, improved quality of life for patients and family caregiver...
Detailed Description
Problem: patients undergoing HSCT and CAR T-cell therapy experience high symptom burden (physical, psychological, spiritual), lack illness and prognostic understanding (which can adversely impact medi...
Eligibility Criteria
Inclusion
- Inclusion Criteria - Patients
- Clinical diagnosis of hematologic malignancy with scheduled hematopoietic stem cell transplantation or chimeric antigen receptor (CAR) T-cell therapy
- Ability to speak, read, and understand English or, be able to complete questionnaires with minimal assistance required from an interpreter
- Inclusion Criteria - Family Caregivers
- Family caregivers of patients with a clinical diagnosis of hematologic malignancy with scheduled hematopoietic stem cell transplantation or chimeric antigen receptor (CAR) T-cell therapy
- A spouse, relative, or friend, identified by the patient, who either lives with the patient or has in-person contact with the patient at least twice per week. Only one family CG per patient will be asked to participate.
- Ability to speak, read, and understand English or willing to complete questionnaires with minimal assistance required from an interpreter
- Exclusion Criteria - Patients
- Patients undergoing HSCT for a non-malignant hematologic condition
- Inability to provide informed consent
- Exclusion Criterion - Family Caregivers
- \* Inability to provide informed consent
Exclusion
Key Trial Info
Start Date :
April 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT05190653
Start Date
April 8 2022
End Date
December 1 2025
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Centre
Calgary, Alberta, Canada